Use PharmaPath as a stronger starting point, not the final answer.

PharmaPath helps you build a better pharmacy shortlist and review medication-related context before the next step. Place lookup can resolve more countries, but nearby search only opens in United States, Australia (limited). It still does not confirm stock, pickup timing, final price, or transfer success until the pharmacy does.

Open Pharmacy FinderOpen Medication Lookup

The short version

1

Use Pharmacy Finder when the first question is who to call.

2

Use Medication Lookup when the medication itself is the harder question.

3

Call the pharmacy before you travel, transfer, or assume availability.

What PharmaPath is good for.

  • Build a more practical shortlist of pharmacies to call first in geographies with supported medication coverage.
  • Keep country-specific medication context nearby when the call depends on shortage pressure, formulation coverage, or company role metadata.
  • Stay explicit about what the product can guide and what it cannot confirm on your behalf.

What still needs direct confirmation.

  • Current stock on the shelf at a specific store.
  • The exact strength, dosage form, or manufacturer you need.
  • Pickup timing, transfer timing, refill timing, or same-day readiness.
  • Final out-of-pocket price, insurance outcome, or substitution approval.

Coverage by geography.

Search only opens where PharmaPath has both an official shortage or supply-context path and a usable product or company-normalization path it can explain clearly. Google Places reach alone does not open a country.

United States

U.S. medication context uses the existing openFDA-based public record stack.

supported

Public shortage, listing, approval, and recall records do not confirm local pharmacy stock.

Australia

Australia uses the TGA Medicine Shortages reports database for national shortage context and ARTG public summary data for product and sponsor metadata.

limited

Shortage context is national and sponsor-reported. It does not confirm stock at a nearby pharmacy.

Canada

Canada has an official Health Canada Drug Product Database API for product and DIN-owner metadata, but PharmaPath is not yet opening Canadian search coverage.

planned

Health Product Shortages Canada does publish official data, but the production API requires account authentication and the public export workflow still needs a stable ingest path.

Blocked because: Official shortage access still depends on authenticated API use or a brittle public export workflow.

United Kingdom

The U.K. remains gated until PharmaPath has a robust, compliant public shortage and product-normalization path.

planned

Medicines Supply Tool and NHS dm+d normalization are still under evaluation for a stable public integration path.

Blocked because: No production-grade public shortage and product normalization stack is wired yet.

EU/EEA

EU/EEA coverage remains gated until there is an official, stable, maintainable public shortage and product-normalization path per geography.

planned

EMA shortages work is public, but PharmaPath is not assuming ESMP consumer API access or maintainable national-register ingestion.

Blocked because: Official public ingestion paths vary by country and are not production-safe in PharmaPath yet.